- Home
- PCRX vs ACIC Comparison
PCRX vs ACIC Comparison
Compare PCRX & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCRX | ACIC |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 625.2M |
| IPO Year | 2010 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PCRX | ACIC |
|---|---|---|
| Price | $23.86 | $11.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $37.60 | N/A |
| AVG Volume (30 Days) | ★ 744.5K | 315.9K |
| Earning Date | 05-15-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 6.73% |
| EPS Growth | ★ 107.44 | 39.61 |
| EPS | 0.16 | ★ 2.15 |
| Revenue | ★ $541,533,000.00 | $335,439,000.00 |
| Revenue This Year | $9.77 | N/A |
| Revenue Next Year | $9.71 | $3.14 |
| P/E Ratio | $142.69 | ★ $5.18 |
| Revenue Growth | ★ 26.04 | 13.07 |
| 52 Week Low | $18.80 | $9.97 |
| 52 Week High | $27.99 | $13.06 |
Technical Indicators
Market Signals| Indicator | PCRX | ACIC |
|---|---|---|
| Relative Strength Index (RSI) | 59.03 | 49.29 |
| Support Level | $23.10 | $10.96 |
| Resistance Level | $23.82 | $11.85 |
| Average True Range (ATR) | 1.07 | 0.36 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 95.14 | 66.25 |
Price Performance
Historical ComparisonAbout PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.